SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has announced plans for a conference call and webcast to be held on Aug. 8, 2024, at 5 p.m. ET. According to the announcement, the company plans to release its financial results for second quarter 2024 after market close on the same day. During the conference call, company leaders will review those results. Those who wish to access the call may dial (844) 308-3351 or (412) 317-5407. A replay of the event will be available on the company website for seven days. Those wishing to access the replay may dial (877) 344-7529 or (412) 317-0088, and then use replay access code 6578863. A webcast replay will be available on the company’s website for 90 days.
To view the webcast, visit https://ibn.fm/TfQoW
To view the full press release, visit https://ibn.fm/eLF2C
About SenesTech Inc.
SenesTech is committed to improving the health of the world by humanely managing animal-pest populations through fertility control. SenesTech invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve and Evolve Mouse, an EPA-designated, minimum-risk contraceptive for rodents, reflecting the company’s mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. SenesTech strives for clean cities, efficient businesses and happy households — with a product designed to be humane, effective and sustainable. For more information about the company, please visit www.SenesTech.com.
NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]
InvestorWire is powered by IBN